The virtual clinical trial space exploded during the COVID-19 pandemic. So, what’s it like to be the CEO of a company skyrocketing at the center of the clinical trial revolution? Medable founder and CEO Michelle Longmire sits down with Beyond the Molecule to explore how Medable empowers clinicians to develop patient-centric research strategies. Listen as she discusses how she has coped with the rapid success that saw the company's revenue grow by more than 500% in 2020, and what the future holds for decentralized clinical trials and digital endpoints.

Listen Here